Tag: Anticoagulants
ASH: Reduced-Dose Anticoagulants Not Noninferior for Recurrent VTE
Noninferiority of reduced-dose anticoagulants could not be proven in patients with VTE who need extended anticoagulation
Bleeding Risk Increased With NSAID Use for VTE Patients Receiving Anticoagulants
More than twofold increased bleeding rate seen with NSAID use for patients treated with oral anticoagulants for VTE
Tenecteplase Has Similar Safety to TPA for Acute Ischemic Stroke
TNK associated with higher likelihood of excellent functional outcome and reduced disability at three months
Early Adoption of DOAC Dashboard Reduces Off-Label Prescribing
Adoption of DOAC population management tool dashboard before July 2018 linked to decline in off-label dosing prescriptions
Oversight of DOAC Prescribing Beneficial for A-Fib, VTE Patients
Oversight identifies errors, especially in a-fib patients, who mainly have alerts for off-label prescribing during follow-up period
Pharmacist Prescribing Can Reduce Stroke Risk in A-Fib Patients
Findings seen for pharmacist prescribing compared with usual care in older adults at high risk for stroke
Low Incidence of Delayed Intracranial Hemorrhage Seen in Seniors After Head Injury
No differences seen in rates of delayed ICH between those who have been versus those who have not been prescribed anticoagulants
Disparities in Direct Oral Anticoagulant Initiation Have Declined in Recent Years
Findings seen for Black and Hispanic patients with atrial fibrillation versus White patients
ASA: Door-to-Treatment Time Tied to Survival in Anticoagulation-Linked ICH
Reduced mortality and discharge to hospital seen with DTT of 60 minutes or less among ICH patients receiving anticoagulation reversal
Ischemic Strokes Less Severe With Left Atrial Appendage Closure in A-Fib
Ischemic stroke less often disabling or fatal with left atrial appendage closure than direct oral anticoagulant prophylaxis
